Development and Validation of the Korean Version of the Edinburgh Cognitive and Behavioral Amyotrophic Lateral Sclerosis Screen (ECAS-K)
	    		
		   		
		   			
		   		
	    	
    	- Author:
	        		
		        		
		        		
			        		Jeeun LEE
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Ahwon KIM
			        		
			        		;
		        		
		        		
		        		
			        		Seok-Jin CHOI
			        		
			        		;
		        		
		        		
		        		
			        		Eric CHO
			        		
			        		;
		        		
		        		
		        		
			        		Jaeyoung SEO
			        		
			        		;
		        		
		        		
		        		
			        		Seong-il OH
			        		
			        		;
		        		
		        		
		        		
			        		Jinho JUNG
			        		
			        		;
		        		
		        		
		        		
			        		Ji-Sun KIM
			        		
			        		;
		        		
		        		
		        		
			        		Jung-Joon SUNG
			        		
			        		;
		        		
		        		
		        		
			        		Sharon ABRAHAMS
			        		
			        		;
		        		
		        		
		        		
			        		Yoon-Ho HONG
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:ORIGINAL ARTICLE
 - From:Journal of Clinical Neurology 2023;19(5):454-459
 - CountryRepublic of Korea
 - Language:English
 - 
		        	Abstract:
			       	
			       		
				        
				        	 Background:and Purpose Cognitive and behavioral changes are common in amyotrophic lateral sclerosis (ALS), with about 15% of patients presenting with overt frontotemporal dementia and 30%–50% with varying degrees of impairments. We aimed to develop and validate the Korean version of the Edinburgh Cognitive and Behavioral ALS Screen (ECAS-K), a brief multidomain assessment tool developed for ALS patients with physical disability. 
				        	
Methods:We developed the ECAS-K according to the translation guidelines, and administered it to 38 patients with ALS and 26 age- and education-level-matched controls. We also administered the Montreal Cognitive Assessment (MoCA) and Frontal Assessment Battery (FAB) to investigate convergent validity, and the Center for Neurologic Study-Liability Scale to assess the association between pseudobulbar affect and cognitive/behavioral changes.
Results:Internal consistency among the ECAS-K test items was found to be high, with a Cronbach’s alpha of 0.87. Significant differences were found between patients with ALS and the controls in language, fluency, and memory functions (p<0.05). Abnormal performance based on the ECAS total score was noted in 39.4% of patients, and 66.6% presented behavioral changes in at least one domain. Significant correlations were observed between the scores of the ECAS-K and those of other cognitive screening tools (MoCA and FAB, with correlation coefficients of 0.69 and 0.55, respectively; p<0.01).
Conclusions:We developed and validated the ECAS-K which could be used as an effective tool to screen the cognitive and behavioral impairments in Korean patients with ALS. 
            